Pharmaceuticals, Biotechnology and Life Sciences
LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi USA, LLC is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill…
LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd (“ EMMAC” or the “ Company”), the European independent medical cannabis company, is pleased to…
VALLEY FORGE, Pa.–(BUSINESS WIRE)–AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq:DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics, today…
WALTHAM, Mass.–(BUSINESS WIRE)–Morphic Holding, Inc. (“Morphic”), a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the closing…
Amid Oasmia’s decision to report certain suspicious transactions that has been made by to company during several years, to the Swedish authority, Sven Rohmann, has today been appointed as acting CEO of the company, to replace the present CEO, Mikael Asp.
Basilea Pharmaceutica has enrolled the first patient in a newly opened cohort in the ongoing FIDES-01 phase 2 registrational study with the panFGFR kinase inhibitor derazantinib in intrahepatic cholangiocarcinoma (iCCA).
New Jersey Expansion Broadens Service Portfolio Currently Offered in Maryland EWING, N.J.–(BUSINESS WIRE)–#NewJersey—Smithers Avanza, a contract research organization (CRO) supporting…
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the publication of a manuscript describing the…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global upper respiratory tract infection treatment market is expected to post a CAGR close to 4% during the…